Style | Citing Format |
---|---|
MLA | Farmani AR, et al.. "An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19." Drug Delivery and Translational Research, vol. 12, no. 7, 2022, pp. 1605-1615. |
APA | Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, Shoormeij MH, Rezaei N (2022). An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19. Drug Delivery and Translational Research, 12(7), 1605-1615. |
Chicago | Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, Shoormeij MH, Rezaei N. "An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19." Drug Delivery and Translational Research 12, no. 7 (2022): 1605-1615. |
Harvard | Farmani AR et al. (2022) 'An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19', Drug Delivery and Translational Research, 12(7), pp. 1605-1615. |
Vancouver | Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, et al.. An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19. Drug Delivery and Translational Research. 2022;12(7):1605-1615. |
BibTex | @article{ author = {Farmani AR and Mahdavinezhad F and Scagnolari C and Kouhestani M and Mohammadi S and Ai J and Shoormeij MH and Rezaei N}, title = {An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19}, journal = {Drug Delivery and Translational Research}, volume = {12}, number = {7}, pages = {1605-1615}, year = {2022} } |
RIS | TY - JOUR AU - Farmani AR AU - Mahdavinezhad F AU - Scagnolari C AU - Kouhestani M AU - Mohammadi S AU - Ai J AU - Shoormeij MH AU - Rezaei N TI - An Overview on Tumor Treating Fields (Ttfields) Technology As a New Potential Subsidiary Biophysical Treatment for Covid-19 JO - Drug Delivery and Translational Research VL - 12 IS - 7 SP - 1605 EP - 1615 PY - 2022 ER - |